Use of cannabinoids in the treatment of epilepsy
US-2020352878-A1 · Nov 12, 2020 · US
This page is not indexed by search engines while we improve data quality.
Gw Pharma Ltd patents in 2020
Gw Pharma Ltd was listed as an assignee on 14 patent publications in 2020.
| Metric | Value |
|---|---|
| Company | Gw Pharma Ltd |
| Year | 2020 |
| Patents | 14 |
Patents
Representative publications for Gw Pharma Ltd in 2020.
Pharmaceutical formulation
US-10807777-B2 · Oct 20, 2020 · US
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy
US-10799467-B2 · Oct 13, 2020 · US
Extraction of pharmaceutically active components from plant materials
US-2020306328-A1 · Oct 1, 2020 · US
Use of cannabidiol in the treatment of epilepsy
US-10765643-B2 · Sep 8, 2020 · US
Top CPC classifications
Most common classification codes for Gw Pharma Ltd in 2020.
| CPC | Patents |
|---|---|
| A61K31/658 | 14 |
| A61K31/05 | 13 |
| A61K36/185 | 12 |
| A61K36/3482 | 12 |
| A61K31/352 | 11 |
Related pages
Navigate to parent entity pages.